Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.
Takahashi K, Urabe F, Suhara Y, Nakano J, Yoshihara K, Goto Y, Sadakane I, Koike Y, Yata Y, Suzuki H, Kurawaki S, Miyajima K, Iwatani K, Imai Y, Sakanaka K, Nakazono M, Kurauchi T, Kayano S, Onuma H, Aikawa K, Yanagisawa T, Tashiro K, Tsuzuki S, Koike Y, Furuta A, Miki J, Kimura T. Takahashi K, et al. Among authors: suzuki h. Jpn J Clin Oncol. 2023 Dec 7;53(12):1208-1214. doi: 10.1093/jjco/hyad118. Jpn J Clin Oncol. 2023. PMID: 37647644
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
Kadena S, Urabe F, Iwatani K, Suzuki H, Imai Y, Tashiro K, Tsuzuki S, Honda M, Koike Y, Shimomura T, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Kadena S, et al. Among authors: suzuki h. Int J Clin Oncol. 2023 Aug;28(8):1092-1100. doi: 10.1007/s10147-023-02359-1. Epub 2023 May 25. Int J Clin Oncol. 2023. PMID: 37227547
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
Miyajima K, Suzuki H, Urabe F, Iwatani K, Imai Y, Yasue K, Yanagisawa T, Kimura S, Tashiro K, Tsuzuki S, Koike Y, Miki J, Yuen S, Sasaki T, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Miyajima K, et al. Among authors: suzuki h. Int J Clin Oncol. 2023 Sep;28(9):1200-1206. doi: 10.1007/s10147-023-02383-1. Epub 2023 Jul 11. Int J Clin Oncol. 2023. PMID: 37432614
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series.
Urabe F, Iwatani K, Hashimoto M, Suzuki H, Miyajima K, Murakami M, Tashiro K, Tsuzuki S, Furuta A, Sato S, Takahashi H, Kimura T. Urabe F, et al. Among authors: suzuki h. Transl Androl Urol. 2023 Aug 31;12(8):1321-1325. doi: 10.21037/tau-23-203. Epub 2023 Aug 10. Transl Androl Urol. 2023. PMID: 37680224 Free PMC article.
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis.
Miyajima K, Sato S, Uchida N, Suzuki H, Iwatani K, Imai Y, Aikawa K, Yanagisawa T, Kimura S, Tashiro K, Tsuzuki S, Honda M, Koike Y, Miki J, Miki K, Shimomura T, Yuen S, Yamada Y, Aoki M, Takahashi H, Urabe F, Kimura T. Miyajima K, et al. Among authors: suzuki h. Clin Genitourin Cancer. 2024 Apr;22(2):149-156.e1. doi: 10.1016/j.clgc.2023.10.005. Epub 2023 Oct 25. Clin Genitourin Cancer. 2024. PMID: 38007354
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study.
Nakano J, Urabe F, Kiuchi Y, Takamizawa S, Suzuki H, Kawano S, Miyajima K, Fukuokaya W, Takahashi K, Iwatani K, Imai Y, Kayano S, Aikawa K, Yanagisawa T, Tashiro K, Yuen S, Sato S, Tsuzuki S, Miki J, Kimura T; JIKEI‐YAYOI Collaborative Group. Nakano J, et al. Among authors: suzuki h. Int J Urol. 2024 Apr;31(4):394-401. doi: 10.1111/iju.15375. Epub 2023 Dec 27. Int J Urol. 2024. PMID: 38151321
Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective study.
Muramoto K, Urabe F, Koike Y, Yamamoto S, Suzuki H, Miyajima K, Fukuokaya W, Iwatani K, Imai Y, Igarashi T, Mori K, Aikawa K, Kimura S, Tashiro K, Yamada Y, Sasaki T, Sato S, Yuen SKK, Shimomura T, Furuta A, Tsuzuki S, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group. Muramoto K, et al. Among authors: suzuki h. Urol Oncol. 2024 Oct;42(10):332.e21-332.e32. doi: 10.1016/j.urolonc.2024.04.001. Epub 2024 May 9. Urol Oncol. 2024. PMID: 38729868
15,216 results
You have reached the last available page of results. Please see the User Guide for more information.